Cetera Advisor Networks’s Anavex Life Sciences AVXL Stock Holding History

Cetera Advisor Networks’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-59,664	Closed	-$555K	–	2818
2023 Q4	$555K	Sell	59,664 -9,212	-13%	-$63.4K	﹤0.01%	1793
2023 Q3	$451K	Sell	68,876 -14,802	-18%	-$118K	﹤0.01%	1837
2023 Q2	$680K	Buy	83,678 +4,833	+6%	+$41.4K	﹤0.01%	1518
2023 Q1	$676K	Buy	78,845 +9,287	+13%	+$92.7K	0.01%	1483
2022 Q4	$644K	Buy	69,558 +6,622	+11%	+$70.7K	0.01%	1464
2022 Q3	$649K	Buy	62,936 +4,655	+8%	+$49.1K	0.01%	1132
2022 Q2	$583K	Buy	58,281 +4,628	+9%	+$43.8K	0.01%	1171
2022 Q1	$660K	Buy	53,653 +21,785	+68%	+$268K	0.01%	1127
2021 Q4	$553K	Buy	31,868 +794	+3%	+$15.1K	0.01%	1221
2021 Q3	$558K	Buy	+31,074	New	+$619K	0.01%	1151

Other funds holding AVXL

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Cetera Advisor Networks's AVXL Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Anavex Life Sciences (AVXL) in Q1 2024, closing a stake of 59,664 shares — an estimated $555K sold.

Cetera Advisor Networks first reported a position in AVXL in Q3 2021 and held it in 10 quarters. The position peaked at $680K in Q2 2023. 147 funds tracked by Wall St. Rank hold AVXL as of Q1 2024.

Cetera Advisor Networks reported no remaining Anavex Life Sciences position as of Q1 2024 after selling out during the quarter.
Cetera Advisor Networks sold 59,664 Anavex Life Sciences shares in Q1 2024, an estimated $555K.
Cetera Advisor Networks first reported a position in Anavex Life Sciences in Q3 2021 and held it in 10 quarters.
Cetera Advisor Networks's Anavex Life Sciences position peaked at $680K in Q2 2023.
147 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.